Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific
Islands and the Americas, whereas type 2 (HTLV-2) is widely distributed among the …

Human T-cell lymphotropic virus type 1 (HTLV-1) is endemic in many parts of the world and
is primarily transmitted through sexual intercourse or from mother to child. Sexual …

Human T-cell lymphotropic viruses type 1 and 2 are retroviruses that share the same routes
of transmission as HIV-1. Since these agents are prevalent simultaneously in different parts …

Human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I) are
two retroviruses that attack the immune cells and impair their functions. Both HIV and HTLV-I …

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) and Cancer-Related
Fatigue (CRF) are syndromes with considerable overlap with respect to symptoms. There …

Aim To perform a systematic review to describe the available findings on clinical outcomes
in HIV-1 and HTLV-1/HTLV-2 co-infected individuals since 1995. Design This Systematic …

In the last 10 years HIV-1/human T-cell leukemia virus (HIV-1/HTLV) coinfection has
emerged as a worldwide health problem. The numbers of HIV-1/HTLV-1 coinfections in …

Retroviral coinfections with HIV-1 and HTLV-1 or with HIV-1 and HTLV-2 occur with variable
frequencies throughout the world with the highest prevalence in large metropolitan areas in …

Thrombocytopenia is a clinically relevant outcome in HIV. However, the epidemiology of this
condition, including frequency, severity, and duration, has not been well-characterized in the …